Symphony Medical name change
This article was originally published in The Gray Sheet
Executive Summary
Development-stage heart failure device maker changes its name to CardioPolymers to reflect its "focus on employing natural biocompatible polymer implants to treat cardiac patients - specifically, congestive heart failure patients with an enlarged left ventricle," according to CEO Raymond Cohen